Søren Knud Carlsen
Direttore/Membro del Consiglio presso Tekniikan Akatemia -säätiö sr
Provenienza dei contatti di primo grado di Søren Knud Carlsen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
| Extinct | Food: Specialty/Candy | 18 | |
Tekniikan Akatemia -säätiö sr
 Tekniikan Akatemia -säätiö sr Investment Trusts/Mutual FundsMiscellaneous Tekniikan Akatemia -säätiö sr, also known as Technology Academy Finland (TAF), is based in Helsinki, Finland. The CEOs of the Finnish company are Mikko Salaspuro and Ainomaija Susanna Haarla. TAF awards the €1 million Millennium Technology Prize and organizes associated events and initiatives. The private company provides an international meeting ground for corporate life, academia, and policymakers, and promotes Finland's position in the community. The Millennium Technology Prize is the world's most prestigious award for breakthrough innovations that improve the quality of people's lives.
16
| Private Company | Investment Trusts/Mutual Funds | 16 |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark.
12
| Operating Division | Investment Managers | 12 |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Biosyntia ApS
 Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark.
7
| Holding Company | Biotechnology | 7 |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark.
5
| Operating Division | Investment Managers | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Søren Knud Carlsen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NOKIA OYJ | Telecommunications Equipment | Chief Tech/Sci/R&D Officer Chief Executive Officer Public Communications Contact | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Human Resources Officer Chief Tech/Sci/R&D Officer | |
| BIOHIT OYJ | Medical Specialties | Director/Board Member Founder Director/Board Member | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| FORTUM OYJ | Alternative Power Generation | Chief Executive Officer Director/Board Member | |
| KONECRANES OYJ | Trucks/Construction/Farm Machinery | Chief Executive Officer Chief Executive Officer Sales & Marketing | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Chief Investment Officer Chief Executive Officer | |
| BIOPORTO A/S | Medical Specialties | Director/Board Member Chief Operating Officer Chief Operating Officer | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
Chr. Hansen A/S
 Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| University of Aarhus | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Aalto University | College/University | Corporate Officer/Principal Director/Board Member Graduate Degree Corporate Officer/Principal | |
| University of Helsinki | College/University | Doctorate Degree Graduate Degree Graduate Degree Corporate Officer/Principal | |
| NEVRO CORP. | Medical Specialties | Director/Board Member Director/Board Member | |
| European Industrial Research Management Association | Director/Board Member Director/Board Member | ||
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
Elinkeinoelämän Keskusliitto ry
 Elinkeinoelämän Keskusliitto ry Miscellaneous Commercial ServicesCommercial Services Elinkeinoelämän Keskusliitto ry is a business organization based in Helsinki, Finland. and has subsidiaries in Finland. The Finnish company operates as a business organization. The CEO of the private company is Jyri Jukka Häkämies. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
East Office of Finnish Industries Oy
 East Office of Finnish Industries Oy Miscellaneous Commercial ServicesCommercial Services East Office of Finnish Industries Oy operates as a business association. The private company is based in Helsinki, Finland. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member Chairman | |
Teknologiateollisuus ry
 Teknologiateollisuus ry Miscellaneous Commercial ServicesCommercial Services Teknologiateollisuus ry operates as a lobbying organization for technology industry companies. It promotes the competitiveness of the Finnish technology industries and communicates about the diversity and significance of the industries. The company was founded on September 13, 1978 and is headquartered in Helsinki, Finland. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree Doctorate Degree | |
| INOZYME PHARMA, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chief Investment Officer Corporate Officer/Principal Corporate Officer/Principal | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Founder | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Energiateollisuus ry | Chairman Director/Board Member | ||
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member |
Statistiche
Distribuzione geografica
| Danimarca | 20 |
| Stati Uniti | 16 |
| Finlandia | 12 |
| Francia | 3 |
| Canada | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 10 |
| Finance | 4 |
| Commercial Services | 4 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 681 |
| Corporate Officer/Principal | 206 |
| Chairman | 188 |
| Independent Dir/Board Member | 162 |
| Chief Executive Officer | 84 |
Contatti più connessi
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Jack Nielsen | 38 |
| Martin Edwards | 38 |
| Jerome Zeldis | 38 |
| Deepa Pakianathan | 32 |
| Richard H. Aldrich | 31 |
| Carl Goldfischer | 31 |
| Robert Spiegel | 30 |
| Nanna Liebach Lüneborg | 29 |
| Stephan Christgau | 29 |
| Stig Gustavson | 29 |
| Lars Vinge Frederiksen | 29 |
| Michael Schmertzler | 28 |
| Peter Bisgaard | 28 |
| Claus Tycho Bræstrup | 27 |
- Borsa valori
- Insiders
- Søren Knud Carlsen
- Connessioni Società